Urinary fibrin split products in lupus nephritis.

Thomas M. Zizic, W. F. Cwazka, N. S. Young, M. B. Stevens

Research output: Contribution to journalArticle

Abstract

Antigen-antibody interaction and fibrin deposition at the glomerular basement membrane can release activators that ultimately convert fibrin into degradation products of varying molecular size. Thus, increased urinary fibrinogen/fibrin split products (FSP) might be expected in active lupus nephritis. A longitudinal study was done on 27 patients with biopsy-proven lupus nephritis. Those patients who were persistent FSP excretors were found to be at a significantly greater risk of progressive nephritis and renal death than those who were FSP negative. It is suggested that FSP excretion in lupus nephritis, particularly on a continued basis and despite normalization of other renal disease parameters, is a grave prognostic sign.

Original languageEnglish (US)
Pages (from-to)43-49
Number of pages7
JournalJournal of Rheumatology
Volume3
Issue number1
Publication statusPublished - Mar 1976
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

Zizic, T. M., Cwazka, W. F., Young, N. S., & Stevens, M. B. (1976). Urinary fibrin split products in lupus nephritis. Journal of Rheumatology, 3(1), 43-49.